» Articles » PMID: 30236826

Depressive Symptoms May Increase the Risk of the Future Development of Freezing of Gait in Patients with Parkinson's Disease: Findings from a 5-year Prospective Study

Overview
Specialty Neurology
Date 2018 Sep 22
PMID 30236826
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Prospective studies identifying predictors of freezing of gait (FOG) in Parkinson's disease (PD) are limited. We aim to explore which symptoms are associated with future development of FOG in non-freezers.

Methods: Fifty-seven PD patients without FOG at baseline were re-evaluated after a mean of five years. At baseline, disease severity [Unified Parkinson's Disease Rating Scale (MDS-UPDRS)], gait under single and dual-tasking, balance, cognition and other non-motor symptoms were assessed. The new-FOG-questionnaire (NFOG-Q) determined FOG. Multivariate binary logistic regression determined independent predictors of FOG.

Results: At follow-up, 26 subjects (46%) had FOG while 31 remained non-freezers. At baseline, non-freezers (FOG-) and future freezers (FOG+) were similar (p > 0.10) with respect to age, gender, disease duration, dopaminergic medications, and cognitive function. However, FOG + had significantly worse scores on the Geriatric Depression Scale (GDS) (FOG+:5.2 ± 3.7; FOG-:2.4 ± 2.0, p = 0.005), PDQ-39, the NMS-questionnaire, UPDRS-part I, UPDRS-part III (off), and the Berg Balance Scale. In binary logistic regression, GDS, gait speed and UPDRS-III (on vs. off) were the only significant independent predictors of future FOG (GDS: OR = 10.93, p = 0.003, ΔUPDRS-III: OR = 1.34, p = 0.006). Moreover, 80% of the subjects who had marked depressive symptoms at baseline (GDS≥5) developed FOG at follow-up. In contrast, only 27% of those with few depressive symptoms at baseline became freezers (p < 0.001).

Conclusions: Depressive symptoms apparently precede the development of FOG. While elucidation of the relationship between depression and FOG needs further study, our findings offer another perspective regarding the pathophysiology of FOG and may help clinicians to estimate the risk of developing this debilitating phenomenon.

Citing Articles

Effects of Smile Training on Gait Disturbance in Parkinson's Disease Patient with Neuropsychiatric Symptoms: A Single Case Design.

Harada Y, Iwabe T, Ota K, Hamada S, Moriwaka F Phys Ther Res. 2025; 27(3):173-179.

PMID: 39866393 PMC: 11756565. DOI: 10.1298/ptr.E10290.


Botulinum Toxin Effects on Freezing of Gait in Parkinson's Disease: A Systematic Review.

Tambasco N, Nigro P, Mechelli A, Duranti M, Parnetti L Toxins (Basel). 2024; 16(11).

PMID: 39591229 PMC: 11598804. DOI: 10.3390/toxins16110474.


Neuroanatomical and prognostic associations of depression in Parkinson's disease.

Badenoch J, Paris A, Jacobs B, Noyce A, Marshall C, Waters S J Neurol Neurosurg Psychiatry. 2024; 95(10):966-973.

PMID: 38569876 PMC: 11420750. DOI: 10.1136/jnnp-2023-333007.


The impact of psychiatric comorbidity on Parkinson's disease outcomes: a systematic review and meta-analysis.

Burchill E, Watson C, Fanshawe J, Badenoch J, Rengasamy E, Ghanem D Lancet Reg Health Eur. 2024; 39:100870.

PMID: 38361749 PMC: 10867667. DOI: 10.1016/j.lanepe.2024.100870.


High-frequency rTMS over bilateral primary motor cortex improves freezing of gait and emotion regulation in patients with Parkinson's disease: a randomized controlled trial.

Song W, Zhang Z, Lv B, Li J, Chen H, Zhang S Front Aging Neurosci. 2024; 16:1354455.

PMID: 38327498 PMC: 10847258. DOI: 10.3389/fnagi.2024.1354455.